Key idea: ‘Bioconvergence’ brings together experts, processes, and technologies across biotech, software, and engineering.
Original author and publication date: Belen Garijo (World Economic Forum) – January 4, 2023
Futurizonte Editor’s Note: New sciences and a new science are emerging. A new understanding of reality is also dawning.
From the article:
Public confidence in science and trust in scientists has rarely been higher than it is today. Worldwide, most people believe science is the best path toward a better, healthier, and more sustainable future. We must seize this moment to accelerate scientific momentum. One roadblock potentially standing in our way is the traditional silo-based approach to scientific research.
Throughout recent history, scientific disciplines such as biology and chemistry have operated mainly in isolation. However, science has become very complex and highly intertwined in recent decades. Gone are the days when discoveries were made by one scientist sitting alone in a lab. Future breakthroughs will most often occur when different teams collaborate, and complementary technologies converge.
Embracing a multi-disciplinary approach to science will be vital to help solve many of humanity’s biggest challenges, including climate change, chronic disease, and the sustainable supply of food or energy.
We call this new scientific megatrend bioconvergence because it harnesses a diverse mix of experts, processes, and technologies across biotech, software, and engineering.
At Merck KGaA, we are leading the way as a diversified global science and technology company dedicated to advancing human progress. Across life science, healthcare and electronics, we are bringing together the right bioconvergent technologies, knowledge, and partners to accelerate the speed and impact of scientific discovery.